FDA Enables Generic Insulins with Lower Prices
Insulin Nation
MARCH 26, 2020
On March 23, 2020, an application for a biological product approved under the Federal Food, Drug, and Cosmetic Act (FD&C Act), including applications for insulins and other biological products, will be deemed to be a license for the product under the Public Health Service (PHS) Act,” explains a recent report from the FDA.
Let's personalize your content